All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 198 of 206 pages ‹ First < 196 197 198 199 200 > Last ›
HSL8471
 Klein T.
 Going public: promoting prescription drugs to consumers 
 Pharmaceutical Executive 1982 Jun;2:46, 50, 52
 
HSL8472
 Meyers HM.
 Packaging: will advertising change prescription drug labeling? 
 Pharmaceutical Executive 1982 Jun;2:44-45
 
HSL8470
 Gunston G.
 Pharmaceutical marketing: predicting prescribing response 
 Pharmaceutical Journal 1982 May 29;228:619-620
 
HSL3126
 The WHO and the pharmaceutical industry
 1982 May 01;
 
HSL3102
 Cohn JN.
 Science and advertising.
 Circulation 1982 May;65:(5):839-40
 
HSL3123
 Strickland-Hodge B, Jepson MH.
 Identification and characterization of early and late prescribers in general practice.
 J R Soc Med 1982 May;75:(5):341-5
 
HSL8473
 Accept no substitutes 
 Pharmaceutical Journal 1982 Apr 17;28:440-441
 
HSL3121
 Soffer A.
 Free medical publications or scientific medical journals.
 Chest 1982 Apr;81:(4):397-8
 
HSL3124
 Tse CS.
 Disclosure of product information by manufacturers.
 Am J Hosp Pharm 1982 Apr;39:(4):645-6
 
HSL8526
 Meadows RJ.
 Prospectus on new drugs 
 Drug Merchandising 1982 Apr;63:18-19
 
HSL8528
 Gunston G.
 Pharmaceutical marketing: kill or cure? 
 Pharmaceutical Journal 1982 Mar 20;228:350
 
HSL13326
 Zelino R.
 The Interaction among the Criteria Physicians Use When Prescribing
 Medical Care 1982 Mar;20:(3):277-85
 
http://www.lww-medicalcare.com/pt/re/medcare/issuelist.htm
HSL16704
 Wolfe SM.
 Mis-prescribing: causes and remedies.
 Internist 1982 Feb;23:(1):8-10
 
http://www.ncbi.nlm.nih.gov/pubmed/10257494
HSL3114
 O'Brien WM.
 Alleged direct promotion of prescription drugs to consumers.
 N Engl J Med 1982 Jan 21;306:(3):181-2
 
HSL2075
 Kahneman D, Slovic P, Tversky A.
 Judgment under uncertainty: heuristics and biases.
 New York: Cambridge University Press 1982
 
http://www.cambridge.org/uk/catalogue/catalogue.asp?isbn=0521284147
HSL2143
 Haayer F.
 Rational prescribing and sources of information.
 Soc Sci Med 1982;16:(23):2017-23
 
HSL2714
 Buc N.
 Current regulatory issues in marketing prescription drugs: Comparative claims and advertising to consumers
 Food Drug Cosmetic Law Journal 1982;37:402-408
 
HSL3096
 Drugs and the Third World
 Lancet 1982;2:1351
 
HSL3098
 Publicity and the public’s ‘right to know’
 New Zealand Pharmacy 1982;2:(6):19, 22
 
HSL3100
 Blum A.
 The subject of advertising
 Medical Journal of Australia 1982;2:61
 
HSL3101
 Bourbonniere C.
 Ethical issues in sponsorship of CME
 Canadian Medical Association Journal 1982;127:681
 
HSL3103
 Cooperstock R, Hill J.
 The effects of tranquillization:  benzodiazepine use in Canada
 Health and Welfare Canada 1982;
 
HSL3104
 Defesche CL.
 Alleged direct promotion of prescription drugs to consumers
 New England Journal of Medicine 1982;306:182
 
HSL3105
 Dunn E, William JI, Bryans AM, Davis D, Delmore T, Herron A, Krauser J, Scott DJ.
 Continuing medical education in Ontario:  a primary care perspective
 Canadian Family Physician 1982;28:1327-1333
 
HSL3106
 Gass DA.
 Ethical issues in sponsorship of CME
 Canadian Medical Association Journal 1982;127:681
 
HSL3108
 Lanier B.
 Drug company advertising to the public
 JAMA 1982;248:1163
 
HSL3109
 McMillan JH.
 Information about medicines
 New Zealand Medical Journal 1982;95:674-675
 
HSL3110
 Medawar C.
 Marketing and use of pharmaceuticals—bad information means bad medicine
 1982;
 
HSL3111
 Melrose D.
 Bitter pills:  medicines and the Third World poor
 1982;
 
http://publications.oxfam.org.uk/oxfam/display.asp?K=9780855980658&cat=090,280&ob=SORT_DATE/d&m=43&dc=220
HSL3112
 Melville A, Johnson C.
 Cured to death:  the effects of prescription drugs
 1982;
 
HSL3113
 Muller M.
 The health of nations:  a north-south investigation
 : Faber and Faber 1982
 
HSL3116
 Rheinstein PH.
 A head start, a broader audience, and an emphasis on difference: The new frontiers of prescription drug promotion
 Food Drug Cosmetic Law Journal 1982;37:330-335
 
HSL3118
 Silverman M, Lee PR, Lydecker M.
 The drugging of the Third World.
 Int J Health Serv 1982;12:(4):585-96
 
HSL3119
 Silverman M, Lee PR, Lydecker M.
 Prescriptions for death:  the drugging of the Third World
 Berkeley: University of California Press 1982;
 
HSL3122
 Soffer A.
 Hazards in publication of proceedings
 Archives of Internal Medicine 1982;142:2074-2076
 
HSL3125
 Victora CG.
 Statistical malpractice in drug promotion: a case-study from Brazil.
 Soc Sci Med 1982;16:(6):707-9
 
HSL5382
 US Congress, Office of Technology Assessment
  Postmarketing Surveillance of Prescription Drugs
 Washington, DC: US Government Publishing Office 1982
 
HSL8454
 Williams P.
 Cost of tranquilizers 
 Social Science and Medicine 1982;16:(22):1955-1958
 
HSL9075
 Medawar C, Freese B.
 Drug Diplomacy
 London: Social Audit 1982
 
http://www.socialaudit.org.uk/122order.htm#1.22%20How%20to%20order
HSL12508
 Jones S.
 Social marketing: dimensions of power and politics.
 
Eur J Mark 1982;16:(6):46-53
 
http://www.ncbi.nlm.nih.gov/pubmed/12280422
HSL13275
 Hadsall RS, Freeman RA, Norwood GJ.
 Factors related to the prescribing of selected psychotropic drugs by primary care physicians.
 
Soc Sci Med 1982;16:(20):1747-56
 
http://www.ncbi.nlm.nih.gov/pubmed/7178921
HSL16705
 Wolfe SM.
 The marketing of a drug.
 Health Med 1982 Spr;1:(2):31-2
 
http://www.ncbi.nlm.nih.gov/pubmed/10257087
HSL8465
 Baum C, Rheinstein P.
 It is time to change the brief summary? 
 Pharmaceutical Executive 1981 Nov;1:34, 36, 38-39
 
HSL3094
 Richter R.
 Pesticides and pills:  for export only  Part two:  pharmaceuticals
 1981 Oct 24;
 
HSL3095
 Freese B, Medawar C, Herxheimer A.
 No more lomotil for infants.
 Lancet 1981 Oct 10;2:(8250):816-7
 
HSL8532
 Kushner D.
 Growing substitution in chains: how will innovating firms respond? 
 American Druggist 1981 Oct;184:3, 52, 54, 58, 60, 62, 66, 68,
 
HSL3093
 Pazderka B, Rao RC.
 Market share competition in the Canadian prescription drug industry:  a comparison of several therapeutical markets
 1981 Sep;
 
HSL8464
 Thomas WH.
 Substitution and generic products 
 New Zealand Pharmacy 1981 Sep;1:35-37, 43
 
HSL3079
 Koumjian K.
 The use of valium as a form of social control.
 Soc Sci Med [E] 1981 Aug;15:(3):245-9
 
HSL8474
 Rheinstein PH.
 Advertising prescription drugs-first promotional campaign 
 Drug Information Journal 1981 Jul-Dec;15:125-127
 
HSL8529
 Vertes L.
 Interactions of oral antidiabetics 
 Gyogyszereszet 1981 Jul;25:242-243
 
HSL3083
 Oppenheim GL, Erickson SH, Ashworth C.
 The family physician's knowledge of the cost of prescribed drugs.
 J Fam Pract 1981 Jun;12:(6):1027-30
 
HSL8531
 Chiles VK.
 Self-medication triangle: manufacturer, pharmacist and consumer 
 Canadian Pharmaceutical Journal 1981 Jun;114:220-221, 228
 
HSL8538
 Feldmann EG.
 Preclearance of drug products--pharmacy's perspective.
 
Am Pharm 1981 Jun;NS21:(6):26-32
 
HSL3092
 Culliton BJ.
 Biomedical research enters the marketplace
 New England Journal of Medicine 1981 May 14;304:(20):1195-1201
 
HSL3063
 Christensen DB, Bush PJ.
 Drug prescribing: patterns, problems and proposals.
 Soc Sci Med [A] 1981 May;15:(3):
 
HSL8536
 Tidball P.
 The pharmaceutical industry's responsibilities in the prescription process.
 
Can Pharm J 1981 May;114:(5):177-9
 
HSL8475
 Generic Rxs rise by 5.9% as branded Rxs increase by only 1.6% 
 Pharmacy Times 1981 Apr;47:17-25
 
HSL8537
 Martucci HJ, Parry MF.
 Cephalosporin cost reduction.
 
Hosp Formul 1981 Apr;16:(4):396-8,
 
HSL3064
 Curry L, Putnam RW.
 Continuing medical education in Maritime Canada: the methods physicians use, would prefer and find most effective.
 Can Med Assoc J 1981 Mar 1;124:(5):563-6
 
HSL8530
 Pharmacy and manufacturer relations 
 Apothecary 1981 Mar;93:10-17
 
HSL8540
 Strickland HODGE, Jepson MH.
 Typing prescribers by reaction to medical detailing 
 Chemist and Druggist 1981 Feb 21;215:346, 352
 
HSL8535
 Dickinson JG.
 Reagan era and pharmacy 
 Drug Topics 1981 Feb 20;125:40-43
 
HSL3075
 Hemminki E.
 Quality of reports of clinical trials submitted by the drug industry to the Finnish and Swedish control authorities.
 Eur J Clin Pharmacol 1981 Feb;19:(3):157-65
 
HSL3089
 Pharmaceutical prices in Canada:  guiding principles for government policy
 Pharmaceutical Manufacturers Association of Canada 1981 Feb;
 
HSL3074
 Gustafsson LL, Wide K.
 Marketing of obsolete antibiotics in Central America.
 Lancet 1981 Jan 3;1:(8210):31-3
 
HSL18712
 Friedman JA, Alkhateeb W
 Exporting Exploitation: The Dumping of U. Banned Pharmaceuticals in LDC's
 Int Q Community Health Educ 1981 Jan 1;2:(4):289-99
 
http://www.ncbi.nlm.nih.gov/pubmed/20841092
HSL2087
 Fazio RH, Zanna MP.
 Direct experience and attitude-behavior consistency.
  Berkowitz L. Advances in experimental social psychology  New York: Academic Press 1981
 
http://www.amazon.co.uk/exec/obidos/ASIN/0120152134/qid=1124174696/sr=8-5/ref=sr_8_xs_ap_i5_xgl/026-3368758-1517268
HSL3060
 Journal IN.
 Lancet 1981;2:801
 
HSL3061
 Berry EM.
 The evolution of scientific and medical journals
 New England Journal of Medicine 1981;305:400-402
 
HSL3062
 Blum R, Kreitman K.
 Factors affecting individual use of medicines
 1981;122-185
 
HSL3065
 Goldbloom D.
 Drug companies and medical education:  a modest proposal
 McGill Medical Journal 1981;46:(2):24
 
HSL3076
 Hibberd PL, Meadows AJ.
 The pharmaceutical industry as a provider of drug information
 Journal of Research Communication Studies 1981;3:289-297
 
HSL3077
 Hymans R.
 NZ Institute of Medical Representatives
 New Zealand Medical Journal 1981;94:11
 
HSL3078
 Jayasuriya DC.
 Regulating the drug trade in the Third World
 World Health Forum 1981;2:423-426
 
HSL3080
 Leffler KB.
 Persuasion or information?  The economics of prescription drug advertising
 Journal of Law and Economics 1981;24:45-74
 
HSL3081
 Mark JA, Honigman B.
 The weight of evidence
 New England Journal of Medicine 1981;305:175
 
HSL3082
 Meadows R.
 Communicating new drug information—the medium is the message
 Drug Information Journal 1981;15:11-15
 
HSL3084
 Parsons LJ, Abeele PV.
 Analysis of sales call effectiveness
 Journal of Marketing Research 1981;18:107-113
 
HSL3085
 Schneiweiss F.
 Pharmaceutical advertising and the medical journal
 Drug Information Journal 1981;15:193-197
 
HSL3086
 Seaman B, Seaman G.
 Women and the crisis in sex hormones
 1981;
 
HSL3087
 Silverman M, Lydecker M.
 The promotion of prescription drugs and other puzzles
 1981;78-92
 
HSL3088
 Tennent RB.
 Trade representatives
 New Zealand Medical Journal 1981;93:314
 
HSL3090
 Drug and Therapeutics Bulletin
 British Journal of Hospital Medicine 1981;25:309
 
HSL3091
 Turner P.
 Drug and Therapeutics Bulletin
 Drug and Therapeutics Bulletin 1981;25:309
 
HSL8533
 Nordahl V.
 Analgetics sales without prescription-should the selection and consumption be changed? 
 Norsk Farmaceutisk Tidsskrift 1981;89:(1-2):4-7
 
HSL9078
 Melrose D.
 The Great Health Robbery
 : Oxfam 1981
 
HSL19395
 Leffler K
 Persuasion or information? the economics of prescription drug advertising.
  J Law Econ 1981;24:45–74
 
http://www.jstor.org/pss/725202
HSL3059
 Ross V.
 Between bliss and bedlam
 Maclean’s (Toronto) 1980 Dec 838-40, 42, 44
 
HSL3033
 Hemminki E, Falkum E.
 Psychotropic drug registration in the Scandinavian countries: the role of clinical trials.
 Soc Sci Med [Med Psychol Med Sociol] 1980 Dec;14A:(6):547-59
 
HSL3046
 Strickland-Hodge B, Jeqson MH.
 Usage of information sources by general practitioners.
 J R Soc Med 1980 Dec;73:(12):857-62
 
HSL8534
 Bush PJ.
 Prescribing is a social process 
 1980 Nov;1:VIII-X
 
HSL5373
 Relman AS.
 The new medical-industrial complex.
 
N Engl J Med 1980 Oct 23;303:(17):963-70
 
HSL8543
 Makers campaign harder for votes of RPhs dispensing generically 
 American Druggist 1980 Oct;182: 44, 46, 48, 50, 52, 56, 58, 6
 
HSL8527
 Fink JL.
 FDA's dispensing container specifications and the pharmacist 
 Pharm Manage 1980 Sep-Oct;152:197-198
 
HSL3058
 Peart WS.
 The pharmaceutical industry: research and responsibility.
 Lancet 1980 Aug 30;2:(8192):465-6
 
HSL3028
 Epstein P, Yudkin JS.
 Agranulocytosis in Mozambique due to amidopyrine, a drug withdrawn in the west.
 Lancet 1980 Aug 2;2:(8188):254-5
 
HSL18279
 de Andrade CD
 O Homem e o Remédio: Qual o problema (People and medicines: What's wrong?)
 Jornal do Brasil 1980 July 26
 
HSL3029
 Gambrill J, Bridges-Webb C.
 Use of sources of therapeutic and prescribing information by general practitioners.
 Aust Fam Physician 1980 Jul;9:(7):482-4
 
HSL3057
 Siskind V.
 Prescription drug advertising
 Medical Journal of Australia 1980 Jun 14;67:615, 617
 
Page 198 of 206 pages ‹ First < 196 197 198 199 200 > Last ›
 








 


